Start Learning Free

Before You Begin

Question #45270

Difficulty: 8/10 | 🟢 Free

The Question

An experimental drug is administered to primary spermatocytes entering Prophase I of meiosis. The drug induces hyper-acetylation of histone tails, effectively neutralizing the positive charges on their lysine and arginine residues. Which of the following represents the most likely consequence of this treatment?

Options

  • A.

    The bivalents will fail to form during zygotene because insufficient chromatin compaction prevents the assembly of the synaptonemal complex.

  • B.

    Crossing over will be significantly enhanced during pachytene because the loosened chromatin provides easier access for the recombinase enzyme.

  • C.

    The cell will arrest at the diplotene stage due to the inability of the homologous chromosomes to dissolve the synaptonemal complex.

  • D.

    DNA replication will be prematurely re-initiated during the interkinesis stage due to the loss of nucleosome structural integrity.

Check Your Answer

Correct Answer

Step-by-Step Solution

Explanation

How the Examiner Thinks

Comparative_Analysis

Sharpen your ability to evaluate multiple scenarios and distinguish between competing potential answers.

Concepts Behind This Question

Synaptonemal Complex|Histone Octamer Charge Interaction|Chromatin Condensation

Why This Question Is Tricky

Common Mistakes

Conceptual Pivot: Integrating Molecular Basis of Inheritance (DNA packaging via histone charge) with Cell Cycle (Meiosis Prophase I stages).

The primary trap is Option B, which plays on the 'Common Half-Truth' that 'loose chromatin = accessible DNA'.

Students often forget that meiotic crossing over is not merely about enzyme access, but fundamentally requires a highly condensed, organized structural scaffold (synaptonemal complex) assembled during zygotene.

Quick Facts About This Question

Question Information

SubjectBiology
ChapterCell Cycle and Cell Division - Class 11
ConceptSynaptonemal Complex Assembly
Difficulty8
Cognitive Load5
Target Solve Time120 sec
AccessFree